IPP Bureau
SRL Diagnostics launches fatty liver index
By IPP Bureau - July 13, 2022
An algorithm based testing for Fatty Liver Disease
Eversana partners with Compai Pharma to expand commercialisation services across APAC
By IPP Bureau - July 13, 2022
EVERSANA and Compai Pharma will provide medical and commercial resources to healthcare partners
Piramal Pharma Solutions holds opening ceremony for new API Plant at Aurora, Canada
By IPP Bureau - July 13, 2022
Plant is part of the company's CAD $30 million capital investment in the site
Athos announces research collaboration to advance precision medicine in inflammatory bowel disease
By IPP Bureau - July 13, 2022
Athos will perform multi-omic molecular and genetic analyses using biopsies from archived and de-identified Lahey IBD patient samples
ProBioGen partners with Granite Bio for cell line development and GMP manufacturing services
By IPP Bureau - July 13, 2022
Granite Bio's lead candidate is a novel monoclonal antibody for treatment of autoimmune and certain cancer indications. B
Biosyntia closes 1.5 million EUR round to launch world’s first bio-based vitamin B7
By IPP Bureau - July 12, 2022
The round was closed with an investment from the European Circular Bioeconomy Fund (ECBF) and the two existing investors, Sofinnova Partners and Novo Seeds
Zydus gets USFDA’s approval for Empagliflozin, Metformin Hydrochloride tablets
By IPP Bureau - July 12, 2022
Empagliflozin and Metformin Hydrochloride tablets are used with proper diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Healthcare Triangle announces $6.5 million private placement
By IPP Bureau - July 12, 2022
India’s first homegrown mRNA COVID-19 vaccine likely to have low market penetration, says GlobalData
By IPP Bureau - July 11, 2022
Proportion of the eligible population yet to receive a COVID-19 vaccine is comparatively small
Glenmark Pharma launches Minym Gel for acne treatment
By IPP Bureau - July 11, 2022
MINYM can be safely used by patients above 9 years of age.
Piramal Pharma strengthens board by inducting three new board members
By IPP Bureau - July 11, 2022
The appointments will add to the well-diversified experience that currently exists on the PPL board.
MFine and LifeCell form JV ‘LifeWell’
By IPP Bureau - July 11, 2022
LifeWell Raises USD 80M from OrbiMed to Build Large Scale Healthcare Delivery Platform with Full stack Diagnostics~
.png "Feeling younger can help us rehabilitate faster : Study")
Feeling younger can help us rehabilitate faster : Study
By IPP Bureau - July 11, 2022
Researchers from Bar-Ilan University find that even in old age, feeling young can lower the risks of developing physical disability and morbidity
Govt introduces 'Draft of New Drugs, Medical Devices and Cosmetics Bill, 2022'
By IPP Bureau - July 11, 2022
The Bill aims to amend and consolidate the law relating to the import, manufacture, distribution and sale of drugs, medical devices and cosmetics
Themis Medicare’s VIRALEX effective against viral respiratory infections
By IPP Bureau - July 10, 2022
Themis Medicare’s VIRALEX is an effective and safe drug for management of mild to moderate COVID and other acute viral respiratory infections.
